Skip to main content
. 2022 Jan 24;25(3):98. doi: 10.3892/mmr.2022.12614

Figure 2.

Figure 2.

ATL-III inhibits the invasion and migration of IEC-6 cells induced by TGF-β1. (A) Cell morphology after TGF-β1 treatment was observed under a microscope. (B) Cell morphology after ATL-III treatment was observed under a microscope. Magnification, ×200. (C) Migration of IEC-6 cells was detected using a wound healing assay. (D) Cell invasion was detected using a Transwell assay. Histograms of cell (E) migration and (F) invasion rates. (G) Expression level of MMP9, as detected via western blotting. Magnification, ×100. ***P<0.001 vs. control group; ##P<0.01, ###P<0.001 vs. TGF-β1 group; n≥3. ATL-III, atractylenolide III.